Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.

Kartolo, Adi; Deluce, Jasna; Hopman, Wilma M; Liu, Linda; Baetz, Tara; Ernst, Scott; Lenehan, John G

Kartolo, Adi; Deluce, Jasna; Hopman, Wilma M; Liu, Linda; Baetz, Tara; Ernst, Scott; Lenehan, John G.

Affiliation

Kartolo A; Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.
Deluce J; Department of Oncology, University of Western Ontario, London, ON N6A 5W9, Canada.
Hopman WM; Department of Public Health Sciences, Queen's University, Kingston, ON K7L 2V7, Canada.
Liu L; Pulse Infoframe, London, ON N5X 4E7, Canada.
Baetz T; Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.
Ernst S; Department of Oncology, University of Western Ontario, London, ON N6A 5W9, Canada.
Lenehan JG; Department of Oncology, University of Western Ontario, London, ON N6A 5W9, Canada.

Curr Oncol ; 29(3): 1501-1513, 2022 03 01.

Article de En | MEDLINE | ID: mdl-35323326

Sujet(s)
Mots clés

BRAF mutant; immunotherapy; melanoma; targeted therapy; therapy sequencing

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Seconde tumeur primitive / Mélanome Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Curr Oncol Année: 2022 Type de document: Article Pays d'affiliation: Canada

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google